Optimal Duration of GLP-1R Agonist Therapy The optimal duration of GLP-1 receptor agonist (GLP-1 RA) therapy for weight loss remains a subject of ongoing research and debate
Or comes with dizziness, weakness, fainting, shortness of breath, or vomiting blood
Choose complex carbs like brown rice or quinoa instead of simple sugars to help maintain stable blood sugar
Key Facts The Absolute Risk Expansion: The calculated increase in absolute risk is remarkably small, manifesting as approximately 3 to 4 additional cases of ischemic optic neuropathy per 10,000 patients treated with GLP-1 receptor agonists over a standard 18-month therapeutic window
The requirements can vary based on the plan, but theyll typically require additional documentation from a qualified healthcare provider
This effect is thought to involve GLP-1 and a related hormone, peptide YY (PYY)